The Better Care Reconciliation Act (BCRA) would cap Medicaid funding to states. In this analysis, Avalere worked with The SCAN Foundation to examine how BCRA Medicaid changes would impact dual-eligible beneficiaries. We compare these outcomes to the impact of the House-approved American Health Care Act.
New analysis from Avalere finds that states could see federal funding for their Medicaid programs decline by between 6% and 26% under the Better Care Reconciliation Act (BCRA) by 2026.
Learn more about how new models of care are impacting providers as Avalere experts discuss care coordination and care transitions.
Today, the Centers for Medicare & Medicaid Services (CMS) released the proposed rule that makes changes to the Quality Payment Program (QPP) for 2018, the second year of the program created by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
The 21st Century Cures Act presents medical product manufacturers, patient groups, and advocacy organizations with a unique opportunity to plan for upcoming policy changes that are aimed at accelerating the pace of development and approval of new therapies.
More than 40% of counties could see only one exchange plan in 2018, with risk that some counties may have no commercial options.
The number of CMS-approved QCDRs tied to payment grows by more than 60% in 2017.
On Tuesday, June 13, Christie Teigland, PhD, will participate in a panel discussion entitled “Measuring and Reporting Social Risk Factors” as part of a dissemination meeting on the report series “Accounting for Social Risk Factors in Medicare Payment,” sponsored by the National Academies of Medicine.
Avalere experts examine the challenges and successful approaches to outcomes-based contracts.
Tom Kraus, who most recently served as the chief of staff at the FDA, will be joining Avalere as senior vice president.
Biosimilars have the opportunity to foster competition, but policy and market barriers limit the growth of a functioning market.
Avalere experts say use of outcomes-based contracts could further goals to improve patient outcomes and manage drug costs
Blog post features key learnings from the Patient-Perspective Value Framework.
Today, the Trump Administration released its budget for fiscal year 2018 (FY 2018). The budget provides the President's recommendations for how the Congress should fund the government and marks the beginning of the FY 2018 budget season.
Across 8 therapeutic areas, the Veteran's Administration (VA) National Formulary covers 49 percent fewer drugs than Ohio's largest Medicaid managed care plan and 68 percent fewer drugs than the Ohio Medicaid preferred drug list (PDL).
In the second interview of our health technology series, we discuss the promise of telehealth technologies with Jamey Edwards, CEO of Cloudbreak Health.
All 50 states and DC would receive fewer Medicaid dollars for non-disabled children.
As the industry continues to see a shift from volume to value, Avalere experts examine the future of Medicare's Quality Payment Program under a new administration.
The elimination of cost-sharing reductions could lead to low-income individuals facing higher deductibles and maximum out-of-pockets.
Today, Avalere and FasterCures published Version 1.0 of the Patient-Perspective Value Framework (PPVF).
